12.42
0.27 (2.22%)
0.27 (2.22%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.27 | 2.22% | 12.42 | 11.90 | 12.72 | 12.09 | 12.15 | 14:14:18 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 12.41 | 12.46 | 0.05 | 0.4% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,637 | 372,169 | $ 12.40 | $ 4,615,850 | 5,234,170 | 1.50 - 13.93 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:14:23 | 25 | $ 12.435 | USD |
Celldex Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 482.24M | 38.83M | 38.81M | $ 3.57M | $ - | -3.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.64 | 13.8785 | 11.7501 | 12.44 | 629,708 | -1.22 | -8.94% |
| 1 Month | 4.42 | 13.93 | 4.2901 | 9.73 | 6,552,201 | 8.00 | 181.0% |
| 3 Months | 1.93 | 13.93 | 1.87 | 8.14 | 2,944,285 | 10.49 | 543.52% |
| 6 Months | 2.59 | 13.93 | 1.50 | 7.51 | 1,516,079 | 9.83 | 379.54% |
| 1 Year | 2.71 | 13.93 | 1.50 | 7.05 | 814,749 | 9.71 | 358.3% |
| 3 Years | 2.51 | 13.93 | 0.17 | 2.42 | 1,435,134 | 9.91 | 394.82% |
| 5 Years | 24.68 | 28.08 | 0.17 | 4.57 | 1,750,966 | -12.26 | -49.68% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379. |
